
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours
Schram, Alison M., Gandhi, Leena, Mita, Monica M., Damstrup, Lars, Campana, Frank, Hidalgo, Manuel, Grande, Enrique, Hyman, David M., Heist, Rebecca S.Langue:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0322-4
Date:
November, 2018
Fichier:
PDF, 475 KB
english, 2018